Status:
COMPLETED
Percutaneous Versus Endoscopic Ultrasound-guided Liver Biopsy (PEREUS)
Lead Sponsor:
Hospital Clinico Universitario de Santiago
Conditions:
Liver Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Although the use of liver biopsy (LB) has decreased with the emerging non-invasive markers and techniques to evaluate liver fibrosis, histopathologic examination of liver tissue is necessary to confir...
Detailed Description
LB remains the gold standard diagnostic test for most of the focal and parenchymal liver diseases. LB has an important diagnostic role in selected parenchymal liver diseases such as autoimmune hepatit...
Eligibility Criteria
Inclusion
- Patients for whom a liver biopsy have been indicated.
- Age over 18 years, any gender
- Understanding and informed consent signed
- Fit for deep sedation
Exclusion
- Age below 18 years
- Not signed informed consent
- Contraindication for a deep sedation
- Pregnancy
- Focal liver lesion that requires biopsy visualized by other imaging techniques
- Coagulopathy (INR\>1.5 or platelets \< 50,000)
- Inability to withdraw anticoagulant or antithrombotic agents
Key Trial Info
Start Date :
January 19 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
92 Patients enrolled
Trial Details
Trial ID
NCT05295537
Start Date
January 19 2022
End Date
December 1 2022
Last Update
March 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinico Universitario de Santiago
Santiago de Compostela, A Coruña, Spain, 15706